Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05898789 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Virtual Rehabilitation for Cancer Survivors

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years 3 months later Jun 30, 2026 → Sep 30, 2028
See other at-risk trials from University Health Network, Toronto

Record History

  1. Primary completion pushed from Jun 30, 2026 to Sep 30, 2028 Completion pushed from Nov 30, 2026 to Nov 30, 2028 · Eligibility criteria expanded, about 13 words · Secondary endpoints: details revised at 8 of 14 entries · 2 more Show 5 more changesShow less
    • Completion pushed from Nov 30, 2026 to Nov 30, 2028
    • Eligibility criteria expanded, about 13 words
    • Secondary endpoints: details revised at 8 of 14 entries
    • Study description expanded, about 6 words
    • Collaborators expanded, about 14 words
  2. Eligibility criteria expanded, about 79 words Study description expanded, about 484 wordsv5 Show 1 more changeShow less
    • Study description expanded, about 484 words

    See this version in full on ClinicalTrials.gov ↗

  3. Primary completion date: May 30, 2025 to Jun 30, 2026 Completion date: Aug 31, 2025 to Nov 30, 2026v4 Show 1 more changeShow less
    • Completion date: Aug 31, 2025 to Nov 30, 2026
  4. Primary completion date: Jul 2024 to May 30, 2025 Completion date: Feb 2025 to Aug 31, 2025v3 Show 1 more changeShow less
    • Completion date: Feb 2025 to Aug 31, 2025
  5. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Jun 1, 2023 to Jul 7, 2023v2 Show 1 more changeShow less
    • Start date changed from estimate of Jun 1, 2023 to Jul 7, 2023
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pragmatic hybrid type 1 effectiveness-implementation (E-I) trial of a virtual cancer rehabilitation program: The study team will conduct a multi-center hybrid type I effectiveness-implementation study to examine the clinical effectiveness and implementation potential of an 8-week multidimensional virtual cancer rehabilitation intervention (CaRE@Home) for cancer survivors with identified cancer-related impairments on level of overall disability (primary outcome) and patient reported physical and social functioning, anxiety, work status, quality of life, and physiologic changes (secondary outcomes). The study team will conduct a multi-centre pragmatic randomized controlled trial (RCT) (Vancouver, Toronto, Saint John and St. John's) to evaluate effectiveness and using the CIFR, the study team will identify potential factors that may affect successful implementation and integration of CaRE@Home in different cancer settings.
Trial Details
NCT Number NCT05898789
Lead Sponsor University Health Network, Toronto
Collaborators: Horizon Health Network, University of British Columbia, Eastern Regional Health Authority, Alberta Health services
Conditions Breast Cancer, Stage 0, Colorectal Cancer Stage I, Head and Neck Cancer Stage I, Lymphoma, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Colorectal Cancer Stage II +4 more
Enrollment 388 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov